GL1X · GenesisL1 explorer

MolNFT v1 · #107731 · protein

Bromodomain of human BRD9 with N-(1,1-dioxo-1-thian-4-yl)-5-methyl-4- oxo-7-3-(TRIFLUOROMETHYL)PHENYL-4H,5H-thieno-3,2-C-pyridine-2- carboximidamide

4UIV · Bromodomain-containing protein 9: “Bromodomain of human BRD9 with N-(1,1-dioxo-1-thian-4-yl)-5-methyl-4…”. X-ray diffraction, 1 ligand (XZB), 1 pocket (best druggability 0.50). MolNFT v1 #107731 on GenesisL1: 3D structure, binding…

PDB
4UIV
Type
protein
Length
101 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Bromodomain-containing protein 9
UniProt
Q9H8M2
Ligands
XZB
Pockets
1 · best druggability 0.50

Structure

x-ray diffraction · 1 distinct chain · 61% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABromodomain-containing protein 9protein10161% helix, 0% strandQ9H8M2

Ligands and binding sites

  • XZB · N-(1,1-dioxo-1-thian-4-yl)-5-methyl-4-oxo-7-3-(trifluoromethyl)phenyl-4H,5H-thieno-3,2-c-pyridine-2-carboximidamide · ligand · chains A
  • EDO · 1,2-ethanediol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1900.500.8218XZB

Compared structures

  • 4UIV · BROMODOMAIN OF HUMAN BRD9 WITH N-(1,1-dioxo-1-thian-4-yl)-5-methyl-4… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9H8M2 · AlphaFold monomer V2.0 prediction for bromodomain-containing protein 9 (Q9H8M2) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.